GM23651
Fibroblast from Skin, Unspecified
Description:
SELENON-RELATED MYOPATHY;
RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1
SELENOPROTEIN N, 1; SEPN1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
ASHKENAZI JEWISH
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
ISCN
|
46,XY.arr(1-22)x2,(XY)x1
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
7.2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
SEPN1 |
Chromosomal Location |
1p36-p35 |
Allelic Variant 1 |
606210.0006; RIGID SPINE MUSCULAR DYSTROPHY 1 |
Identified Mutation |
713dupA (c.713_714Ins); 1-bp insertion in the SEPN1 gene that was found in compound heterozygous state in patients with multiminicore disease (602771) by Ferreiro et al. (2002) |
|
Gene |
SEPN1 |
Chromosomal Location |
1p36-p35 |
Allelic Variant 2 |
606210.0006; RIGID SPINE MUSCULAR DYSTROPHY 1 |
Identified Mutation |
713dupA (c.713_714Ins); 1-bp insertion in the SEPN1 gene that was found in compound heterozygous state in patients with multiminicore disease (602771) by Ferreiro et al. (2002) |
Remarks |
Clinically affected; onset of symptoms before age 2 years; diagnosed by muscle biopsy and muscle imaging (MRI); normal creatine kinase; no developmental delay; left ventricle shortening fraction is 32%; donor subject is homozygous for a 1 bp duplication at nucleotide 713 in exon 5 of the SEPN1 gene (713dupA) predicted to result in a frameshift and premature protein termination (p.Asn238LysfsStop63); LCL from same subject is GM24369. |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|